Jan. 24, 2020 Immunization provides the best protection against the influenza virus and vaccines have been available for decades with a recent switch from trivalent to quadrivalent vaccines that protect against each two influenza type A and two B strains.

The late stage pipeline for seasonal influenza vaccines in the 3GM includes the first quadrivalent seasonal influenza vaccines in China from Sinovac, Chongqing Zhifei, and Wuhan, as well as a quadrivalent formulation of Fluad.Quadrivalent live-attenuated vaccines will launch in India (from the Serum Institute) and Japan (AstraZeneca’s FluMist, licensed by Daiichi Sankyo).

[link to www.ptcommunity.com (secure)]

“The launch of the first inactivated quadrivalent influenza vaccines in China from Sinovac Biotech, Chongqing Zhifei Biological Products and Wuhan Institute of Biological Products"

[link to www.europeanpharmaceuticalreview.com (secure)]

January 24, 2020 Virus-hit Wuhan has two laboratories linked to Chinese bio-warfare program

[link to m.washingtontimes.com (secure)]

Thread: Virus-hit Wuhan has two laboratories linked to Chinese bio-warfare program

26 January 2020 In 1993, China declared a second facility, the Wuhan Institute of Biological Products, as one of eight biological warfare research facilities covered by the Biological Weapons Convention (BWC) which China joined in 1985.

[link to www.outlookindia.com (secure)]

13 hours ago According to figures compiled by the Center for Systems Science and Engineering, Johns Hopkins University, as of mid-Tuesday morning Beijing time, 4,474 cases of the coronavirus had been confirmed in mainland China, and 107 deaths had been recorded, the vast majority in Hubei province.

[link to cnsnews.com (secure)]

Conclusion; Recently switched Influenza Vaccination was launched by Wuhan Institute of Biological Products and is also a biological warfare research facility.